The tumor strikes back: new data on expression of the CD95(APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology
Cell Death Differ
.
1997 Jul;4(5):362-4.
doi: 10.1038/sj.cdd.4400252.
Author
P H Krammer
PMID:
16465254
DOI:
10.1038/sj.cdd.4400252
No abstract available
Publication types
Editorial